Juha O. Rinne - Concepedia

Author

Juha O. Rinne

Also Known As

A. Benazzouz, Antti Palomäki, Christian Haass, Corbett, Mark, Eric M. Reiman, Esko Levälahti, Francisco López‐Picón, HRRT [11C]PBR28 study group, Hilkka Soininen, I.-M. Jousmaa

616

Publications

32.1K

Citations

H-Index

197

Concepts

All Affiliations

University of Turku Turku PET Centre Turku University Hospital Åbo Akademi University University of Helsinki

About

Juha O. Rinne is an author at University of Turku specializing in neuroscience, medicine, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	51	103	8K
2	Health Sciences	24	31	1.9K
3	Language Studies	4	4	394
4	Engineering	3	3	142
5	Arts	2	2	100

Juha O. Rinne

320

Publications

24.4K

Citations

H-Index

Page 1

	Year	Citations
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study Juha O. Rinne, David J. Brooks, Martin N. Rossor, The Lancet Neurology Neurodegenerative DiseasesAscending-dose StudyAlzheimer's Disease11C-pib Pet AssessmentBiomarkers	2010	694
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers Tiina Pohjalainen, Juha O. Rinne, Kjell Någren, Molecular Psychiatry Functional SelectivityHealthy VolunteersGeneticsPsychopharmacologyNeuroscience	1998	674
Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations: clinical and molecular genetic study Petri Luoma, Atle Melberg, Juha O. Rinne, The Lancet Neurodegenerative DiseasesMolecular Genetic StudyGenetic DisorderParkinson DiseaseGenetics	2004	540
Conversion of amyloid positive and negative MCI to AD over 3 years Aren Okello, J. Koivunen, Paul Edison, Neurology	2009	513
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography Paul Edison, Christopher C. Rowe, Juha O. Rinne, Journal of Neurology Neurosurgery & Psychiatry	2008	427
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease P. M. Mattila, Juha O. Rinne, Hans Helenius, Acta Neuropathologica Alzheimer's DiseaseCorticobasal DegenerationFrontotemporal DementiaNeurologyNeuroscience	2000	362
PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease Minna Oksanen, Andrew J. Petersen, Nikolay Naumenko, Stem Cell Reports	2017	327
PET amyloid ligand [ <sup>11</sup> C]PIB uptake is increased in mild cognitive impairment Nina Kemppainen, Sargo Aalto, Ian A. Wilson, Neurology	2007	309
Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials Rik Vandenberghe, Juha O. Rinne, Merçé Boada, Alzheimer s Research & Therapy	2016	293
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial Catherine J. Mummery, Anne Börjesson‐Hanson, D. Blackburn, Nature Medicine	2023	288

Page 1